Who owns BioMarin Pharmaceutical?

Key details on BioMarin Pharmaceutical (Ticker: BMRN)

Who owns BioMarin Pharmaceutical?

Is BMRN a good stock to own? Find out who bought BioMarin Pharmaceutical, who sold BioMarin Pharmaceutical (BMRN) stock, and who holds a large position in BioMarin Pharmaceutical.

Fund Name Number of Shares Share Valuation As Of
OTR - Nominee Name for The State Teachers Retirement Board of Ohio 38.66M $38.27M March 31, 2015
Capital Research Global Investors^ 15.85M $1.31B March 31, 2016
FMR 13.46M $1.11B March 31, 2016
Sands Capital Management 11.56M $953.59M March 31, 2016
Vanguard 11.20M $1.17B Dec. 31, 2015
Jennison Associates 8.75M $721.69M March 31, 2016
PRIMECAP Management Company 7.35M $606.26M March 31, 2016
T. Rowe Price Associates 6.22M $512.92M March 31, 2016
Columbia Wanger Asset Management 5.67M $279.40M Dec. 31, 2012
Sabby Management 5.00M $6500 Dec. 31, 2015
WINSLOW CAPITAL MANAGEMENT INC /MN 4.82M $328.84M March 31, 2014
Baker Bros. Advisors 4.81M $396.44M March 31, 2016
JPMORGAN CHASE & CO 4.49M $395.88M March 31, 2016
STATE STREET CORPORATION 4.32M $268.63M June 30, 2014
Inves 4.14M $142.44M Dec. 31, 2011
Altrinsic Global Advisors 4.11M $141.20M Dec. 31, 2011

Who sold BioMarin Pharmaceutical?

Fund Name Date Sold Number of Shares Sold Share Valuation
Sectoral Asset Management June 30, 2011 4.79M $130.30M
Cramer Rosenthal McGlynn June 30, 2011 4.54M $123.60M